Salarius Pharmaceuticals, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
Mailing Address 2450 HOLCOMBE BLVD, HOUSTON, TX, 77021
Phone 346-772-0346
Fiscal Year End 1231
EIN 465087339
Financial Overview
FY2024
-$5.58M
Net Income
$6.59M
Total Assets
$1.51M
Total Liabilities
$10.38M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | January 9, 2026 | View on SEC |
| 8-K Current report of material events | January 8, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| 8-K Current report of material events | January 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 2, 2026 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
| 3 Initial insider ownership report | November 24, 2025 | View on SEC |
| 3 Initial insider ownership report | November 24, 2025 | View on SEC |
| 3 Initial insider ownership report | November 24, 2025 | View on SEC |
| 4 Insider stock transaction report | November 24, 2025 | View on SEC |
Material Events
8-K Financial Distress January 2, 2026
High Impact
- Salarius Pharmaceuticals received a notice from Nasdaq regarding delisting due to its common stock's closing bid price falling below $1.00 for 30 consecutive business days.
- The company is not eligible for the usual grace period due to a recent reverse stock split and being under a 'Mandatory Panel Monitor' by Nasdaq.
Insider Trading
BUY 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.